A Novel Inactivated Intranasal Respiratory Syncytial Virus Vaccine Promotes Viral Clearance without Th2 Associated Vaccine-Enhanced Disease

BACKGROUND: Respiratory syncytial virus (RSV) is a leading cause of bronchiolitis and pneumonia in young children worldwide, and no vaccine is currently available. Inactivated RSV vaccines tested in the 1960's led to vaccine-enhanced disease upon viral challenge, which has undermined RSV vaccin...

Descripción completa

Detalles Bibliográficos
Autores principales: Lindell, Dennis M., Morris, Susan B., White, Maria P., Kallal, Lara E., Lundy, Phillip K., Hamouda, Tarek, Baker, James R., Lukacs, Nicholas W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3137595/
https://www.ncbi.nlm.nih.gov/pubmed/21789184
http://dx.doi.org/10.1371/journal.pone.0021823

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3137595/
https://www.ncbi.nlm.nih.gov/pubmed/21789184
http://dx.doi.org/10.1371/journal.pone.0021823

Ejemplares similares